Across the three previous Summer Olympics and Paralympics, Team USA took home an average of 218 medals. The summer trophy ...

For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed ...

The HPV vaccine, which has been on a juggernaut trajectory this decade thanks to booming sales in China, generated revenue of ...

Incyte is gunning for a first-in-class nod for PD-1 inhibitor Zynyz in anal cancer again after being turned away by the FDA ...

Nearly three years after its debut, the Genentech-backed song “Spaces” made it to perhaps its biggest stage yet. | Nearly ...

South Korea’s Ministry of Food and Drug Safety issued a pair of administrative penalties to GSK for manufacturing and ...

In the first half of 2024, sales for WuXi AppTec fell by 9%, to 17.2 billion yuan ($2.4 billion) year over year.

With a phase 3 trial win claimed by AstraZeneca, the heated BTK inhibitor race might see its first triplet regimen in chronic ...

Suboxone maker Indivior has spent years dealing with allegations related to its role in the United States opioid epidemic, ...

A month after a CDC panel narrowed its recommendations for who should receive vaccines to protect against respiratory ...

Kaléo’s engagement with Brittany Mahomes’ 2 million Instagram followers has landed it in the FDA’s bad books. | Kaléo’s ...

Eli Lilly is putting out a new message to mark the start of the Olympic Games: “You only get one body, let's fight like hell ...